Nautilus Biotechnology, Inc. (NAUT)

Last Closing Price: 0.75 (2025-05-30)

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Nautilus Biotechnology, Inc. (NAUT) Receiveable Turnover data is not available.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
--
$-16.61M
--
--
$18.84M
$-18.84M
$2.23M
$-16.61M
$-16.61M
$-16.61M
$-16.61M
$-16.61M
$-16.61M
$-18.84M
$-17.76M
126.14M
126.14M
$-0.13
$-0.13
Balance Sheet Financials
$141.60M
$3.79M
$86.09M
$227.69M
$8.16M
--
$25.10M
$33.26M
$194.44M
$194.44M
$194.44M
126.15M
Cash Flow Statement Financials
$-13.94M
$19.51M
$0.02M
$28.65M
$34.24M
$5.59M
$2.17M
--
--
Fundamental Metrics & Ratios
17.36
--
--
--
--
--
--
--
--
--
--
$-14.16M
--
--
--
--
--
Receiveable Turnover
--
--
-8.54%
-8.54%
-7.30%
-8.54%
$1.54
$-0.11
$-0.11